Booster Doses In India
-
{
- All
- News
- Videos
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Top 5 Vaccine Recommendations For A Healthy 50's
Let's delve into the top five vaccine recommendations that every individual in their 50s should consider to stay fit, strong, and resilient.
-
"For Odisha BJP, Even Booster Dose Will Not Help": Naveen Patnaik's Aide
Hitting back at Prime Minister Narendra Modi's comments relating to the Naveen Patnaik government in Odisha, BJD on Saturday said he comes to give booster dose to state BJP leaders as they as they do not have hope of coming to power.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
Top 5 Vaccine Recommendations For A Healthy 50's
Let's delve into the top five vaccine recommendations that every individual in their 50s should consider to stay fit, strong, and resilient.
-
"For Odisha BJP, Even Booster Dose Will Not Help": Naveen Patnaik's Aide
Hitting back at Prime Minister Narendra Modi's comments relating to the Naveen Patnaik government in Odisha, BJD on Saturday said he comes to give booster dose to state BJP leaders as they as they do not have hope of coming to power.
-
Serum Institute Seeks Inclusion Of Covovax On CoWIN As Booster Dose For Adults
The DCGI approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.
-
New Booster Dose Should Work Against Future Covid Strains: Ex AIIMS Chief
The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Smartwatch Data Shows COVID Booster Dose Safe for Heart: Lancet Study
The booster dose of COVID-19 vaccine is safe, according to a study published in The Lancet Respiratory Medicine that monitored heart measures through smartwatches. Researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches.
